These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6311787)

  • 21. [Effect of synthetic antifungal drugs on the adherence of Candida albicans to the mouth mucosa epithelium in vitro].
    Macura AB; Dwernicka B
    Med Dosw Mikrobiol; 1989; 41(1):67-70. PubMed ID: 2668662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid fluorimetric determination of 5-fluorocytosine in serum.
    Richardson RA
    Clin Chim Acta; 1975 Sep; 63(2):109-14. PubMed ID: 240518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Susceptibility of Candida albicans pretreated with ketoconazole and 5-fluorocytosine to fungicidal activity of leukocytes and serum.
    Chiu ML; Minguez F; Lima JF; Garcia MT; Salazar EF; Prieto J
    J Chemother; 1995 Nov; 7 Suppl 4():21-2. PubMed ID: 8904093
    [No Abstract]   [Full Text] [Related]  

  • 24. Antifungal activity of 5-fluorocytosine as measured by disk diffusion susceptibility testing.
    Utz CJ; Shadomy S
    J Infect Dis; 1977 Jun; 135(6):970-4. PubMed ID: 325150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A simple medium for 5-fluorocytosine sensitiving testing (author's transl)].
    Böhm W
    Dermatol Monatsschr; 1982 May; 168(5):317-20. PubMed ID: 7049776
    [No Abstract]   [Full Text] [Related]  

  • 26. [Relation between the antibiotic concentration and contact time of the effect of 5-fluorocytosine, bifonazole and Bay N 7133 on Candida albicans].
    Rumler W; Heins S; Heins J
    Mykosen; 1984 Sep; 27(9):436-42. PubMed ID: 6390193
    [No Abstract]   [Full Text] [Related]  

  • 27. [Sensitivity of Candida to 5-fluorocytosine and amphotericin B].
    Pawlik B; Budak A; Macura A; Laskownicka Z
    Med Dosw Mikrobiol; 1978; 30(1):43-8. PubMed ID: 692181
    [No Abstract]   [Full Text] [Related]  

  • 28. [Comparative study of two systems for the determination of the sensitivity of yeasts to antifungal agents].
    de Montclos M; de Montclos H; Flandrois JP
    Pathol Biol (Paris); 1992 May; 40(5):495-9. PubMed ID: 1495833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of experimental cryptococcal meningitis with amphotericin B, 5-fluorocytosine, and ketoconazole.
    Perfect JR; Durack DT
    J Infect Dis; 1982 Sep; 146(3):429-35. PubMed ID: 6286799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simplified bioassay method for measurement of flucytosine or ketoconazole.
    Bodet CA; Jorgensen JH; Drutz DJ
    J Clin Microbiol; 1985 Aug; 22(2):157-60. PubMed ID: 4031030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Sensitivity of Candida spp. to 5-fluorocytosine, amphotericin B and imidazoles. Antifongiogram of 120 strains isolated at the Vaudois University Hospital Center during the autumn-winter seasons of 1978 and 1980].
    Sakellarides E
    Schweiz Med Wochenschr; 1981 Sep; 111(37):1367-72. PubMed ID: 7291960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 5-fluorocytosine susceptibility of pathogenic fungi in the presence of allopurinol: potential for improving the therapeutic index of 5-fluorocytosine.
    Kerkering TM; Schwartz PM; Espinel-Ingroff A; Turek PJ; Diasio RB
    Antimicrob Agents Chemother; 1983 Sep; 24(3):448-9. PubMed ID: 6639003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experimental and clinical studies of 5-fluorocytosine activity in Candida ocular infections. I. In vitro activity of 5-fluorocytosine on Candida species isolated from ocular infections.
    Segal E; Romano A; Eylan E; Stein R
    Chemotherapy; 1975; 21(6):358-66. PubMed ID: 1183243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [In vitro sensitivity to 5-fluorocytosine and amphotericin B of yeasts of the Candida genus isolated in Barcelona].
    Torres-Rodríguez JM; Sabaté M; Gallach C; Carrillo A; Madrenys N
    Enferm Infecc Microbiol Clin; 1990 Feb; 8(2):91-3. PubMed ID: 2098147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined in vitro activity of amphotericin B and 5-fluorocytosine against Cryptococcus neoformans and Candida albicans.
    Chen HH; Liushih RN; Hsieh WC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1982 May; 15(2):106-12. PubMed ID: 7047097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of antifungal pretreatment on the susceptibility of Candida albicans to human leukocytes.
    Mínguez Mínguez F; Lima JE; García MT; Prieto J
    Chemotherapy; 1997; 43(5):346-51. PubMed ID: 9309368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Study of the susceptibility of yeast isolates of clinical interest to five antifungal agents using the E test.
    Linares MJ; Muñoz JF; Solís F; Rodríguez FC; Valero A; Casal M
    Rev Esp Quimioter; 1998 Mar; 11(1):64-9. PubMed ID: 9795292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assay for yeast susceptibility to 5-fluorocytosine and amphotericin B in a frozen microtiter system.
    Ellis NS; Bartlett MS; Smith JW
    Am J Clin Pathol; 1979 Aug; 72(2):194-8. PubMed ID: 382827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Choice and monitoring of the treatment of systemic mycoses. Value and limitations of in vitro tests].
    Eloy O; Joly V; Ghnassia JC; Carbon C; Yeni P
    Presse Med; 1992 May; 21(20):937-42. PubMed ID: 1322537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A rapid susceptibility testing method for yeasts to 5-fluorocytosine.
    Scheven M
    Mycoses; 1990; 33(9-10):449-54. PubMed ID: 2093841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.